3.39BMarket Cap-11.06P/E (TTM)
31.690High30.645Low1.23MVolume31.600Open30.930Pre Close38.28MTurnover1.23%Turnover RatioLossP/E (Static)109.43MShares36.60052wk High5.08P/B3.10BFloat Cap13.48052wk Low--Dividend TTM100.04MShs Float193.540Historical High--Div YieldTTM3.38%Amplitude13.480Historical Low31.049Avg Price1Lot Size
Zai Lab Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet